nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—Irbesartan—JUN—sarcoma	0.036	1	CrCbGaD
Valsartan—AGTR1—endothelium—sarcoma	0.0069	0.117	CbGeAlD
Valsartan—SLCO1B1—mammary gland—sarcoma	0.0053	0.0898	CbGeAlD
Valsartan—ALB—mammary gland—sarcoma	0.00429	0.0727	CbGeAlD
Valsartan—AGTR1—myometrium—sarcoma	0.00395	0.0669	CbGeAlD
Valsartan—AGTR1—hematopoietic system—sarcoma	0.00339	0.0574	CbGeAlD
Valsartan—AGTR1—connective tissue—sarcoma	0.00326	0.0553	CbGeAlD
Valsartan—SLCO1B1—hematopoietic system—sarcoma	0.00323	0.0547	CbGeAlD
Valsartan—AGTR1—smooth muscle tissue—sarcoma	0.00298	0.0506	CbGeAlD
Valsartan—SLCO1B3—liver—sarcoma	0.00289	0.049	CbGeAlD
Valsartan—CYP2C9—mammary gland—sarcoma	0.00268	0.0454	CbGeAlD
Valsartan—AGTR1—cardiac atrium—sarcoma	0.00257	0.0436	CbGeAlD
Valsartan—Hypotension—Vincristine—sarcoma	0.00239	0.00265	CcSEcCtD
Valsartan—AGTR1—lymphoid tissue—sarcoma	0.00239	0.0404	CbGeAlD
Valsartan—Anorexia—Mitoxantrone—sarcoma	0.00238	0.00263	CcSEcCtD
Valsartan—Hyponatraemia—Epirubicin—sarcoma	0.00238	0.00263	CcSEcCtD
Valsartan—Renal failure acute—Doxorubicin—sarcoma	0.00237	0.00262	CcSEcCtD
Valsartan—Gastrointestinal pain—Thiotepa—sarcoma	0.00236	0.00261	CcSEcCtD
Valsartan—Gastrointestinal pain—Dactinomycin—sarcoma	0.00234	0.00259	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Vincristine—sarcoma	0.00233	0.00258	CcSEcCtD
Valsartan—Hypotension—Mitoxantrone—sarcoma	0.00233	0.00258	CcSEcCtD
Valsartan—Insomnia—Vincristine—sarcoma	0.00232	0.00256	CcSEcCtD
Valsartan—Renal impairment—Doxorubicin—sarcoma	0.0023	0.00254	CcSEcCtD
Valsartan—Paraesthesia—Vincristine—sarcoma	0.0023	0.00254	CcSEcCtD
Valsartan—Urticaria—Thiotepa—sarcoma	0.0023	0.00254	CcSEcCtD
Valsartan—Dermatitis bullous—Doxorubicin—sarcoma	0.00229	0.00253	CcSEcCtD
Valsartan—Vertigo—Etoposide—sarcoma	0.00228	0.00252	CcSEcCtD
Valsartan—Abdominal pain—Thiotepa—sarcoma	0.00228	0.00252	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00227	0.00251	CcSEcCtD
Valsartan—Abdominal pain—Dactinomycin—sarcoma	0.00227	0.0025	CcSEcCtD
Valsartan—Cardiac failure—Doxorubicin—sarcoma	0.00224	0.00248	CcSEcCtD
Valsartan—AGTR1—tendon—sarcoma	0.00224	0.038	CbGeAlD
Valsartan—Paraesthesia—Mitoxantrone—sarcoma	0.00224	0.00248	CcSEcCtD
Valsartan—Loss of consciousness—Etoposide—sarcoma	0.00224	0.00247	CcSEcCtD
Valsartan—Decreased appetite—Vincristine—sarcoma	0.00223	0.00246	CcSEcCtD
Valsartan—Dyspnoea—Mitoxantrone—sarcoma	0.00222	0.00246	CcSEcCtD
Valsartan—Cough—Etoposide—sarcoma	0.00222	0.00245	CcSEcCtD
Valsartan—Somnolence—Mitoxantrone—sarcoma	0.00222	0.00245	CcSEcCtD
Valsartan—Blood creatinine increased—Epirubicin—sarcoma	0.00222	0.00245	CcSEcCtD
Valsartan—Gastrointestinal disorder—Vincristine—sarcoma	0.00221	0.00244	CcSEcCtD
Valsartan—Fatigue—Vincristine—sarcoma	0.00221	0.00244	CcSEcCtD
Valsartan—Hyponatraemia—Doxorubicin—sarcoma	0.0022	0.00243	CcSEcCtD
Valsartan—Dyspepsia—Mitoxantrone—sarcoma	0.0022	0.00243	CcSEcCtD
Valsartan—Constipation—Vincristine—sarcoma	0.00219	0.00242	CcSEcCtD
Valsartan—Decreased appetite—Mitoxantrone—sarcoma	0.00217	0.0024	CcSEcCtD
Valsartan—Chest pain—Etoposide—sarcoma	0.00216	0.00239	CcSEcCtD
Valsartan—Orthostatic hypotension—Epirubicin—sarcoma	0.00216	0.00239	CcSEcCtD
Valsartan—Abdominal pain upper—Epirubicin—sarcoma	0.00216	0.00239	CcSEcCtD
Valsartan—Fatigue—Mitoxantrone—sarcoma	0.00215	0.00238	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00215	0.00238	CcSEcCtD
Valsartan—Constipation—Mitoxantrone—sarcoma	0.00213	0.00236	CcSEcCtD
Valsartan—Hypersensitivity—Thiotepa—sarcoma	0.00213	0.00235	CcSEcCtD
Valsartan—Hypersensitivity—Dactinomycin—sarcoma	0.00211	0.00233	CcSEcCtD
Valsartan—Gastrointestinal pain—Vincristine—sarcoma	0.0021	0.00231	CcSEcCtD
Valsartan—Muscular weakness—Epirubicin—sarcoma	0.00209	0.00231	CcSEcCtD
Valsartan—Anaphylactic shock—Etoposide—sarcoma	0.00208	0.00229	CcSEcCtD
Valsartan—Asthenia—Thiotepa—sarcoma	0.00207	0.00229	CcSEcCtD
Valsartan—Infection—Etoposide—sarcoma	0.00206	0.00228	CcSEcCtD
Valsartan—Asthenia—Dactinomycin—sarcoma	0.00206	0.00227	CcSEcCtD
Valsartan—Blood creatinine increased—Doxorubicin—sarcoma	0.00205	0.00227	CcSEcCtD
Valsartan—Pruritus—Thiotepa—sarcoma	0.00204	0.00226	CcSEcCtD
Valsartan—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00204	0.00225	CcSEcCtD
Valsartan—Thrombocytopenia—Etoposide—sarcoma	0.00203	0.00225	CcSEcCtD
Valsartan—Abdominal pain—Vincristine—sarcoma	0.00203	0.00224	CcSEcCtD
Valsartan—Skin disorder—Etoposide—sarcoma	0.00202	0.00223	CcSEcCtD
Valsartan—Abdominal pain upper—Doxorubicin—sarcoma	0.002	0.00221	CcSEcCtD
Valsartan—Orthostatic hypotension—Doxorubicin—sarcoma	0.002	0.00221	CcSEcCtD
Valsartan—Urticaria—Mitoxantrone—sarcoma	0.00198	0.00219	CcSEcCtD
Valsartan—Anorexia—Etoposide—sarcoma	0.00198	0.00219	CcSEcCtD
Valsartan—Diarrhoea—Thiotepa—sarcoma	0.00198	0.00218	CcSEcCtD
Valsartan—Abdominal pain—Mitoxantrone—sarcoma	0.00197	0.00218	CcSEcCtD
Valsartan—Bronchitis—Epirubicin—sarcoma	0.00197	0.00217	CcSEcCtD
Valsartan—Diarrhoea—Dactinomycin—sarcoma	0.00196	0.00217	CcSEcCtD
Valsartan—Hypotension—Etoposide—sarcoma	0.00194	0.00214	CcSEcCtD
Valsartan—Muscular weakness—Doxorubicin—sarcoma	0.00193	0.00213	CcSEcCtD
Valsartan—Neutropenia—Epirubicin—sarcoma	0.00191	0.00211	CcSEcCtD
Valsartan—Dizziness—Thiotepa—sarcoma	0.00191	0.00211	CcSEcCtD
Valsartan—Upper respiratory tract infection—Epirubicin—sarcoma	0.0019	0.0021	CcSEcCtD
Valsartan—Hypersensitivity—Vincristine—sarcoma	0.00189	0.00209	CcSEcCtD
Valsartan—Photosensitivity reaction—Epirubicin—sarcoma	0.00187	0.00206	CcSEcCtD
Valsartan—Paraesthesia—Etoposide—sarcoma	0.00186	0.00206	CcSEcCtD
Valsartan—AGTR1—testis—sarcoma	0.00186	0.0315	CbGeAlD
Valsartan—Dyspnoea—Etoposide—sarcoma	0.00185	0.00204	CcSEcCtD
Valsartan—Somnolence—Etoposide—sarcoma	0.00185	0.00204	CcSEcCtD
Valsartan—Hypersensitivity—Mitoxantrone—sarcoma	0.00184	0.00203	CcSEcCtD
Valsartan—Asthenia—Vincristine—sarcoma	0.00184	0.00203	CcSEcCtD
Valsartan—Vomiting—Thiotepa—sarcoma	0.00184	0.00203	CcSEcCtD
Valsartan—Infestation NOS—Epirubicin—sarcoma	0.00182	0.00202	CcSEcCtD
Valsartan—Infestation—Epirubicin—sarcoma	0.00182	0.00202	CcSEcCtD
Valsartan—Vomiting—Dactinomycin—sarcoma	0.00182	0.00201	CcSEcCtD
Valsartan—Rash—Thiotepa—sarcoma	0.00182	0.00201	CcSEcCtD
Valsartan—Bronchitis—Doxorubicin—sarcoma	0.00182	0.00201	CcSEcCtD
Valsartan—Dermatitis—Thiotepa—sarcoma	0.00182	0.00201	CcSEcCtD
Valsartan—Headache—Thiotepa—sarcoma	0.00181	0.002	CcSEcCtD
Valsartan—Rash—Dactinomycin—sarcoma	0.00181	0.002	CcSEcCtD
Valsartan—Decreased appetite—Etoposide—sarcoma	0.0018	0.00199	CcSEcCtD
Valsartan—Renal failure—Epirubicin—sarcoma	0.00179	0.00198	CcSEcCtD
Valsartan—Gastrointestinal disorder—Etoposide—sarcoma	0.00179	0.00198	CcSEcCtD
Valsartan—Asthenia—Mitoxantrone—sarcoma	0.00179	0.00198	CcSEcCtD
Valsartan—Fatigue—Etoposide—sarcoma	0.00179	0.00198	CcSEcCtD
Valsartan—Constipation—Etoposide—sarcoma	0.00177	0.00196	CcSEcCtD
Valsartan—Neutropenia—Doxorubicin—sarcoma	0.00177	0.00196	CcSEcCtD
Valsartan—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00176	0.00194	CcSEcCtD
Valsartan—AGTR1—liver—sarcoma	0.00176	0.0297	CbGeAlD
Valsartan—Diarrhoea—Vincristine—sarcoma	0.00175	0.00194	CcSEcCtD
Valsartan—Photosensitivity reaction—Doxorubicin—sarcoma	0.00173	0.00191	CcSEcCtD
Valsartan—Epistaxis—Epirubicin—sarcoma	0.00172	0.0019	CcSEcCtD
Valsartan—Nausea—Thiotepa—sarcoma	0.00172	0.0019	CcSEcCtD
Valsartan—Sinusitis—Epirubicin—sarcoma	0.00171	0.00189	CcSEcCtD
Valsartan—Diarrhoea—Mitoxantrone—sarcoma	0.00171	0.00189	CcSEcCtD
Valsartan—Nausea—Dactinomycin—sarcoma	0.0017	0.00188	CcSEcCtD
Valsartan—Gastrointestinal pain—Etoposide—sarcoma	0.0017	0.00188	CcSEcCtD
Valsartan—Dizziness—Vincristine—sarcoma	0.00169	0.00187	CcSEcCtD
Valsartan—Infestation NOS—Doxorubicin—sarcoma	0.00169	0.00186	CcSEcCtD
Valsartan—Infestation—Doxorubicin—sarcoma	0.00169	0.00186	CcSEcCtD
Valsartan—SLCO1B1—liver—sarcoma	0.00167	0.0284	CbGeAlD
Valsartan—Renal failure—Doxorubicin—sarcoma	0.00166	0.00183	CcSEcCtD
Valsartan—Urticaria—Etoposide—sarcoma	0.00165	0.00182	CcSEcCtD
Valsartan—Haemoglobin—Epirubicin—sarcoma	0.00165	0.00182	CcSEcCtD
Valsartan—Rhinitis—Epirubicin—sarcoma	0.00164	0.00181	CcSEcCtD
Valsartan—Abdominal pain—Etoposide—sarcoma	0.00164	0.00181	CcSEcCtD
Valsartan—Hepatitis—Epirubicin—sarcoma	0.00164	0.00181	CcSEcCtD
Valsartan—Haemorrhage—Epirubicin—sarcoma	0.00164	0.00181	CcSEcCtD
Valsartan—CYP2C9—hematopoietic system—sarcoma	0.00163	0.0276	CbGeAlD
Valsartan—Vomiting—Vincristine—sarcoma	0.00163	0.0018	CcSEcCtD
Valsartan—Pharyngitis—Epirubicin—sarcoma	0.00163	0.0018	CcSEcCtD
Valsartan—Urinary tract disorder—Epirubicin—sarcoma	0.00162	0.00179	CcSEcCtD
Valsartan—Rash—Vincristine—sarcoma	0.00162	0.00178	CcSEcCtD
Valsartan—Dermatitis—Vincristine—sarcoma	0.00161	0.00178	CcSEcCtD
Valsartan—Connective tissue disorder—Epirubicin—sarcoma	0.00161	0.00178	CcSEcCtD
Valsartan—Urethral disorder—Epirubicin—sarcoma	0.00161	0.00177	CcSEcCtD
Valsartan—Headache—Vincristine—sarcoma	0.00161	0.00177	CcSEcCtD
Valsartan—Epistaxis—Doxorubicin—sarcoma	0.00159	0.00176	CcSEcCtD
Valsartan—Vomiting—Mitoxantrone—sarcoma	0.00159	0.00175	CcSEcCtD
Valsartan—Sinusitis—Doxorubicin—sarcoma	0.00158	0.00175	CcSEcCtD
Valsartan—Rash—Mitoxantrone—sarcoma	0.00157	0.00174	CcSEcCtD
Valsartan—Dermatitis—Mitoxantrone—sarcoma	0.00157	0.00174	CcSEcCtD
Valsartan—Headache—Mitoxantrone—sarcoma	0.00156	0.00173	CcSEcCtD
Valsartan—Hypersensitivity—Etoposide—sarcoma	0.00153	0.00169	CcSEcCtD
Valsartan—Haemoglobin—Doxorubicin—sarcoma	0.00152	0.00168	CcSEcCtD
Valsartan—Nausea—Vincristine—sarcoma	0.00152	0.00168	CcSEcCtD
Valsartan—Cardiac disorder—Epirubicin—sarcoma	0.00152	0.00168	CcSEcCtD
Valsartan—Rhinitis—Doxorubicin—sarcoma	0.00152	0.00168	CcSEcCtD
Valsartan—Haemorrhage—Doxorubicin—sarcoma	0.00152	0.00167	CcSEcCtD
Valsartan—Hepatitis—Doxorubicin—sarcoma	0.00152	0.00167	CcSEcCtD
Valsartan—Pharyngitis—Doxorubicin—sarcoma	0.0015	0.00166	CcSEcCtD
Valsartan—Urinary tract disorder—Doxorubicin—sarcoma	0.0015	0.00165	CcSEcCtD
Valsartan—Asthenia—Etoposide—sarcoma	0.00149	0.00165	CcSEcCtD
Valsartan—Connective tissue disorder—Doxorubicin—sarcoma	0.00149	0.00165	CcSEcCtD
Valsartan—Angiopathy—Epirubicin—sarcoma	0.00149	0.00164	CcSEcCtD
Valsartan—Urethral disorder—Doxorubicin—sarcoma	0.00149	0.00164	CcSEcCtD
Valsartan—Nausea—Mitoxantrone—sarcoma	0.00148	0.00164	CcSEcCtD
Valsartan—Immune system disorder—Epirubicin—sarcoma	0.00148	0.00163	CcSEcCtD
Valsartan—Mediastinal disorder—Epirubicin—sarcoma	0.00148	0.00163	CcSEcCtD
Valsartan—Pruritus—Etoposide—sarcoma	0.00147	0.00162	CcSEcCtD
Valsartan—Alopecia—Epirubicin—sarcoma	0.00145	0.0016	CcSEcCtD
Valsartan—Mental disorder—Epirubicin—sarcoma	0.00143	0.00159	CcSEcCtD
Valsartan—ALB—testis—sarcoma	0.00143	0.0243	CbGeAlD
Valsartan—Malnutrition—Epirubicin—sarcoma	0.00143	0.00158	CcSEcCtD
Valsartan—Diarrhoea—Etoposide—sarcoma	0.00142	0.00157	CcSEcCtD
Valsartan—Cardiac disorder—Doxorubicin—sarcoma	0.00141	0.00155	CcSEcCtD
Valsartan—Flatulence—Epirubicin—sarcoma	0.0014	0.00155	CcSEcCtD
Valsartan—Dysgeusia—Epirubicin—sarcoma	0.0014	0.00154	CcSEcCtD
Valsartan—Back pain—Epirubicin—sarcoma	0.00138	0.00152	CcSEcCtD
Valsartan—Angiopathy—Doxorubicin—sarcoma	0.00137	0.00152	CcSEcCtD
Valsartan—Dizziness—Etoposide—sarcoma	0.00137	0.00152	CcSEcCtD
Valsartan—Muscle spasms—Epirubicin—sarcoma	0.00137	0.00151	CcSEcCtD
Valsartan—Immune system disorder—Doxorubicin—sarcoma	0.00137	0.00151	CcSEcCtD
Valsartan—Mediastinal disorder—Doxorubicin—sarcoma	0.00137	0.00151	CcSEcCtD
Valsartan—ALB—liver—sarcoma	0.00135	0.0229	CbGeAlD
Valsartan—AGTR1—lymph node—sarcoma	0.00135	0.0228	CbGeAlD
Valsartan—Vision blurred—Epirubicin—sarcoma	0.00134	0.00148	CcSEcCtD
Valsartan—Alopecia—Doxorubicin—sarcoma	0.00134	0.00148	CcSEcCtD
Valsartan—Mental disorder—Doxorubicin—sarcoma	0.00133	0.00147	CcSEcCtD
Valsartan—Vomiting—Etoposide—sarcoma	0.00132	0.00146	CcSEcCtD
Valsartan—Malnutrition—Doxorubicin—sarcoma	0.00132	0.00146	CcSEcCtD
Valsartan—Rash—Etoposide—sarcoma	0.00131	0.00145	CcSEcCtD
Valsartan—Dermatitis—Etoposide—sarcoma	0.00131	0.00144	CcSEcCtD
Valsartan—Headache—Etoposide—sarcoma	0.0013	0.00144	CcSEcCtD
Valsartan—Flatulence—Doxorubicin—sarcoma	0.0013	0.00144	CcSEcCtD
Valsartan—Dysgeusia—Doxorubicin—sarcoma	0.00129	0.00143	CcSEcCtD
Valsartan—Vertigo—Epirubicin—sarcoma	0.00128	0.00142	CcSEcCtD
Valsartan—Syncope—Epirubicin—sarcoma	0.00128	0.00141	CcSEcCtD
Valsartan—Back pain—Doxorubicin—sarcoma	0.00128	0.00141	CcSEcCtD
Valsartan—Muscle spasms—Doxorubicin—sarcoma	0.00127	0.0014	CcSEcCtD
Valsartan—Palpitations—Epirubicin—sarcoma	0.00126	0.00139	CcSEcCtD
Valsartan—Loss of consciousness—Epirubicin—sarcoma	0.00125	0.00138	CcSEcCtD
Valsartan—Cough—Epirubicin—sarcoma	0.00124	0.00137	CcSEcCtD
Valsartan—Vision blurred—Doxorubicin—sarcoma	0.00124	0.00137	CcSEcCtD
Valsartan—Nausea—Etoposide—sarcoma	0.00123	0.00136	CcSEcCtD
Valsartan—Arthralgia—Epirubicin—sarcoma	0.00121	0.00134	CcSEcCtD
Valsartan—Myalgia—Epirubicin—sarcoma	0.00121	0.00134	CcSEcCtD
Valsartan—Chest pain—Epirubicin—sarcoma	0.00121	0.00134	CcSEcCtD
Valsartan—Anxiety—Epirubicin—sarcoma	0.00121	0.00134	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00121	0.00133	CcSEcCtD
Valsartan—Dry mouth—Epirubicin—sarcoma	0.00119	0.00131	CcSEcCtD
Valsartan—Vertigo—Doxorubicin—sarcoma	0.00118	0.00131	CcSEcCtD
Valsartan—Syncope—Doxorubicin—sarcoma	0.00118	0.00131	CcSEcCtD
Valsartan—Palpitations—Doxorubicin—sarcoma	0.00117	0.00129	CcSEcCtD
Valsartan—Anaphylactic shock—Epirubicin—sarcoma	0.00116	0.00129	CcSEcCtD
Valsartan—Oedema—Epirubicin—sarcoma	0.00116	0.00129	CcSEcCtD
Valsartan—Loss of consciousness—Doxorubicin—sarcoma	0.00116	0.00128	CcSEcCtD
Valsartan—Infection—Epirubicin—sarcoma	0.00116	0.00128	CcSEcCtD
Valsartan—Cough—Doxorubicin—sarcoma	0.00115	0.00127	CcSEcCtD
Valsartan—Shock—Epirubicin—sarcoma	0.00114	0.00126	CcSEcCtD
Valsartan—Nervous system disorder—Epirubicin—sarcoma	0.00114	0.00126	CcSEcCtD
Valsartan—Thrombocytopenia—Epirubicin—sarcoma	0.00114	0.00126	CcSEcCtD
Valsartan—Skin disorder—Epirubicin—sarcoma	0.00113	0.00125	CcSEcCtD
Valsartan—Arthralgia—Doxorubicin—sarcoma	0.00112	0.00124	CcSEcCtD
Valsartan—Chest pain—Doxorubicin—sarcoma	0.00112	0.00124	CcSEcCtD
Valsartan—Myalgia—Doxorubicin—sarcoma	0.00112	0.00124	CcSEcCtD
Valsartan—Anxiety—Doxorubicin—sarcoma	0.00112	0.00124	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00112	0.00123	CcSEcCtD
Valsartan—Anorexia—Epirubicin—sarcoma	0.00111	0.00123	CcSEcCtD
Valsartan—Dry mouth—Doxorubicin—sarcoma	0.0011	0.00121	CcSEcCtD
Valsartan—Hypotension—Epirubicin—sarcoma	0.00109	0.0012	CcSEcCtD
Valsartan—Anaphylactic shock—Doxorubicin—sarcoma	0.00108	0.00119	CcSEcCtD
Valsartan—Oedema—Doxorubicin—sarcoma	0.00108	0.00119	CcSEcCtD
Valsartan—Infection—Doxorubicin—sarcoma	0.00107	0.00118	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00106	0.00117	CcSEcCtD
Valsartan—Shock—Doxorubicin—sarcoma	0.00106	0.00117	CcSEcCtD
Valsartan—Nervous system disorder—Doxorubicin—sarcoma	0.00106	0.00117	CcSEcCtD
Valsartan—Thrombocytopenia—Doxorubicin—sarcoma	0.00105	0.00116	CcSEcCtD
Valsartan—Insomnia—Epirubicin—sarcoma	0.00105	0.00116	CcSEcCtD
Valsartan—Skin disorder—Doxorubicin—sarcoma	0.00105	0.00116	CcSEcCtD
Valsartan—Paraesthesia—Epirubicin—sarcoma	0.00104	0.00115	CcSEcCtD
Valsartan—ALB—lymph node—sarcoma	0.00104	0.0176	CbGeAlD
Valsartan—Dyspnoea—Epirubicin—sarcoma	0.00104	0.00115	CcSEcCtD
Valsartan—Somnolence—Epirubicin—sarcoma	0.00103	0.00114	CcSEcCtD
Valsartan—Anorexia—Doxorubicin—sarcoma	0.00103	0.00113	CcSEcCtD
Valsartan—Dyspepsia—Epirubicin—sarcoma	0.00102	0.00113	CcSEcCtD
Valsartan—Decreased appetite—Epirubicin—sarcoma	0.00101	0.00112	CcSEcCtD
Valsartan—Hypotension—Doxorubicin—sarcoma	0.00101	0.00111	CcSEcCtD
Valsartan—Gastrointestinal disorder—Epirubicin—sarcoma	0.001	0.00111	CcSEcCtD
Valsartan—Fatigue—Epirubicin—sarcoma	0.001	0.00111	CcSEcCtD
Valsartan—Constipation—Epirubicin—sarcoma	0.000995	0.0011	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000981	0.00108	CcSEcCtD
Valsartan—Insomnia—Doxorubicin—sarcoma	0.000974	0.00108	CcSEcCtD
Valsartan—Paraesthesia—Doxorubicin—sarcoma	0.000967	0.00107	CcSEcCtD
Valsartan—Dyspnoea—Doxorubicin—sarcoma	0.00096	0.00106	CcSEcCtD
Valsartan—Somnolence—Doxorubicin—sarcoma	0.000957	0.00106	CcSEcCtD
Valsartan—Gastrointestinal pain—Epirubicin—sarcoma	0.000951	0.00105	CcSEcCtD
Valsartan—Dyspepsia—Doxorubicin—sarcoma	0.000948	0.00105	CcSEcCtD
Valsartan—Decreased appetite—Doxorubicin—sarcoma	0.000936	0.00103	CcSEcCtD
Valsartan—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000929	0.00103	CcSEcCtD
Valsartan—Fatigue—Doxorubicin—sarcoma	0.000928	0.00103	CcSEcCtD
Valsartan—Urticaria—Epirubicin—sarcoma	0.000924	0.00102	CcSEcCtD
Valsartan—Constipation—Doxorubicin—sarcoma	0.000921	0.00102	CcSEcCtD
Valsartan—Abdominal pain—Epirubicin—sarcoma	0.00092	0.00102	CcSEcCtD
Valsartan—Gastrointestinal pain—Doxorubicin—sarcoma	0.00088	0.000973	CcSEcCtD
Valsartan—Hypersensitivity—Epirubicin—sarcoma	0.000857	0.000947	CcSEcCtD
Valsartan—Urticaria—Doxorubicin—sarcoma	0.000855	0.000945	CcSEcCtD
Valsartan—Abdominal pain—Doxorubicin—sarcoma	0.000851	0.00094	CcSEcCtD
Valsartan—CYP2C9—liver—sarcoma	0.000845	0.0143	CbGeAlD
Valsartan—Asthenia—Epirubicin—sarcoma	0.000835	0.000922	CcSEcCtD
Valsartan—Pruritus—Epirubicin—sarcoma	0.000823	0.000909	CcSEcCtD
Valsartan—Diarrhoea—Epirubicin—sarcoma	0.000796	0.00088	CcSEcCtD
Valsartan—Hypersensitivity—Doxorubicin—sarcoma	0.000793	0.000876	CcSEcCtD
Valsartan—Asthenia—Doxorubicin—sarcoma	0.000772	0.000853	CcSEcCtD
Valsartan—Dizziness—Epirubicin—sarcoma	0.000769	0.00085	CcSEcCtD
Valsartan—Pruritus—Doxorubicin—sarcoma	0.000762	0.000842	CcSEcCtD
Valsartan—Vomiting—Epirubicin—sarcoma	0.00074	0.000817	CcSEcCtD
Valsartan—Diarrhoea—Doxorubicin—sarcoma	0.000737	0.000814	CcSEcCtD
Valsartan—Rash—Epirubicin—sarcoma	0.000734	0.000811	CcSEcCtD
Valsartan—Dermatitis—Epirubicin—sarcoma	0.000733	0.00081	CcSEcCtD
Valsartan—Headache—Epirubicin—sarcoma	0.000729	0.000805	CcSEcCtD
Valsartan—Dizziness—Doxorubicin—sarcoma	0.000712	0.000787	CcSEcCtD
Valsartan—Nausea—Epirubicin—sarcoma	0.000691	0.000764	CcSEcCtD
Valsartan—Vomiting—Doxorubicin—sarcoma	0.000684	0.000756	CcSEcCtD
Valsartan—Rash—Doxorubicin—sarcoma	0.000679	0.00075	CcSEcCtD
Valsartan—Dermatitis—Doxorubicin—sarcoma	0.000678	0.000749	CcSEcCtD
Valsartan—Headache—Doxorubicin—sarcoma	0.000674	0.000745	CcSEcCtD
Valsartan—Nausea—Doxorubicin—sarcoma	0.000639	0.000706	CcSEcCtD
